DelistingMay 4, 2026, 08:02 AM
Jaguar Health faces Nasdaq delisting for insufficient public shares
AI Summary
Jaguar Health, Inc. received a notice from Nasdaq on May 1, 2026, stating non-compliance with the minimum 500,000 Publicly Held Shares requirement. Following a 1-for-35 reverse stock split, the company has approximately 401,226 publicly held shares, which is below the Nasdaq Listing Rule 5550(a)(4) threshold. This deficiency serves as an additional basis for delisting, and the company also remains non-compliant with the minimum $1 bid price requirement. Jaguar Health must submit its views to the Nasdaq Hearings Panel by May 8, 2026, and while it is working to regain compliance, there is no assurance it will succeed, risking delisting.
Key Highlights
- Nasdaq notified Jaguar Health of non-compliance with Rule 5550(a)(4) on May 1, 2026.
- Post-reverse stock split, publicly held shares are approximately 401,226, below the 500,000 minimum.
- This non-compliance serves as an additional basis for delisting the company's securities from Nasdaq.
- Jaguar Health also remains non-compliant with the minimum $1 bid price requirement.
- The company must present its views to the Nasdaq Hearings Panel by May 8, 2026.
- There is no assurance that the company will be able to satisfy the requirements and avoid delisting.